Dong Linda 4

What Happened Linda Dong, a director of Astrana Health, was granted 4,525 restricted shares of the company's common stock on 2026-06-10. The shares were issued as an award at $0.00 per share (acquisition value $0). This is a compensation award rather than an open‑market purchase or sale.

Key Details

• Transaction date and type: 2026-06-10 — Award/grant of 4,525 restricted shares at $0.00.
• Vesting: The restricted shares vest on the earlier of (i) June 10, 2027 or (ii) the date of Astrana Health's 2027 annual meeting of stockholders (per footnotes).
• Shares owned after transaction: The filing reports the 4,525 restricted shares granted; it does not state a total post-transaction beneficial ownership in the provided excerpt.
• Filing timeliness: No late-filing indication provided in the supplied data.
• Plan/authority: Grants made pursuant to the Issuer's 2024 Equity Incentive Plan (footnote detail).

Context Restricted stock grants to directors are typically part of routine compensation and vest over time; they do not represent an immediate purchase or sale of shares and do not by themselves indicate a near-term trading intention. For retail investors, such awards signal standard director compensation and should be interpreted differently from an insider buying shares on the open market.